Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Disorders of Breast”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT06613230
What this trial is testing

Improved Early Diagnosis in Female Pelvic Cancer With OC Detect

Who this might be right for
Ovarian CancerEndometrial CancerBreast Cancer+3 more
Region Skane 490
Testing effectiveness (Phase 2)UnknownNCT00280930
What this trial is testing

Letrozole in Postmenopausal Women at Increased Risk for Breast Cancer

Who this might be right for
Post-MenopausalBreast Cancer
Dana-Farber Cancer Institute 60
Testing effectiveness (Phase 2)Ended earlyNCT00694200
What this trial is testing

Vinorelbine Metronomic Plus Bevacizumab as Salvage Therapy for Breast Cancer

Who this might be right for
Breast Cancer
Hellenic Oncology Research Group 13
Not applicableStudy completedNCT02479607
What this trial is testing

Effects of an ICT-platform for Assessment and Management of Patient-reported Symptoms During Treatment for Breast Cancer

Who this might be right for
Breast Cancer
Karolinska Institutet 150
Not applicableLooking for participantsNCT06274892
What this trial is testing

Remote Monitoring of Patient Reported Outcomes to Improve the Efficacy of the Acute Phase Radiotherapy Review Process

Who this might be right for
Prostate CancerBreast Cancer
University Health Network, Toronto 124
Large-scale testing (Phase 3)Study completedNCT00060320
What this trial is testing

Black Cohosh in Treating Hot Flashes in Women Who Have or Who Are At Risk of Developing Breast Cancer

Who this might be right for
Breast CancerHot Flashes
Alliance for Clinical Trials in Oncology 132
Testing effectiveness (Phase 2)Active Not RecruitingNCT04692103
What this trial is testing

Serial FES PET/CT to Measure Hormone Expression in Patients Undergoing Endocrine Targeted Therapy

Who this might be right for
Estrogen Receptor PositivePrimary or Recurrent Breast CarcinomaStage IV Breast Cancer AJCC v6 and v7
University of Washington 2
Not applicableWithdrawnNCT03091842
What this trial is testing

Exercise Intervention in Targeting Adiposity and Inflammation With Movement to Improve Prognosis in Breast Cancer

Who this might be right for
Cancer SurvivorCentral ObesityEstrogen Receptor Positive+12 more
University of Southern California
Not applicableEnded earlyNCT00925405
What this trial is testing

Breast Magnetic Resonance Imaging (MRI) Screening After Mantle Radiation Therapy

Who this might be right for
Breast Cancer
M.D. Anderson Cancer Center 10
Not applicableStudy completedNCT06534957
What this trial is testing

Online Mindfulness-based Stress Reduction for Patients Receiving Chemotherapy

Who this might be right for
Breast CancerStress
Medicos e Investigadores en la Lucha contra el Cancer de Mama 128
Not applicableStudy completedNCT05217381
What this trial is testing

Real-World Data of Clinicopathological Characteristics and Management of Breast Cancer Patients According to HER2 Status

Who this might be right for
Early Breast CancerMetastatic Breast CancerLocally Advanced Breast Cancer
MedSIR 18,533
Testing effectiveness (Phase 2)Ended earlyNCT04171700
What this trial is testing

Evaluate Rucaparib in Participants With Solid Tumors and With Deleterious Mutations in HRR Genes

Who this might be right for
Solid Tumor
pharmaand GmbH 83
Testing effectiveness (Phase 2)Study completedNCT01941407
What this trial is testing

First Line Metastatic Breast Cancer Treatment (ESMERALDA)

Who this might be right for
Metastatic Breast Cancer
ARCAGY/ GINECO GROUP 61
Testing effectiveness (Phase 2)Study completedNCT03193853
What this trial is testing

TAK-228 and TAK-117 Followed by Cisplatin and Nab Paclitaxel for Metastatic Triple Negative Breast Cancer

Who this might be right for
Triple Negative Breast Cancer
Joyce O'Shaughnessy 12
Post-approval studies (Phase 4)UnknownNCT00912639
What this trial is testing

A Clinical Trial of Paclitaxel Loaded Polymeric Micelle in Patients With Taxane-Pretreated Recurrent Breast Cancer

Who this might be right for
Recurrent Breast Cancer
Korean Breast Cancer Study Group 90
Not applicableUnknownNCT03983577
What this trial is testing

Efficacy of Point Of Service Testing in MBC

Who this might be right for
Metastatic CancerBreast Cancer
University of Kansas Medical Center 100
Not applicableUnknownNCT05483712
What this trial is testing

Brass Mesh Bolus in Rotational Post-Mastectomy Radiation Therapy

Who this might be right for
Breast Cancer
Nova Scotia Cancer Centre 20
Not applicableStudy completedNCT07778407
What this trial is testing

TDXD in Metastatic HER2-Positive Breast Cancer

Who this might be right for
Breast Advanced Malignancies
Mansoura University 25
Large-scale testing (Phase 3)Study completedNCT02028507
What this trial is testing

Phase III Palbociclib With Endocrine Therapy vs. Capecitabine in HR+/HER2- MBC With Resistance to Aromatase Inhibitors

Who this might be right for
Metastatic Breast Cancer
Spanish Breast Cancer Research Group 693
Not applicableActive Not RecruitingNCT05912231
What this trial is testing

Ultrahypofractionation and Normal Tissue Toxicity

Who this might be right for
Breast CancerBreast Cancer FemaleBreast Cancer Stage II+2 more
Massachusetts General Hospital 60
Next Page